Continuous glucose dynamics monitoring in diabetic patients with peritoneal dialysis
Keywords:
Blood glucose, diabetes mellitus, extracellular fluid, peritoneal dialysisAbstract
Background : Glucose dynamics in patients on peritoneal dialysis (PD) is influenced by many factors.
Objectives : We evaluated the dynamics of interstitial fluid (ISF) glucose in diabetic patients undergoing PD, controlled for caloric food intake, daily activities, and hypoglycemic agents.
Methods : We studied all type-2 diabetic patients at the PD clinic of King Chulalongkorn Memorial Hospital between 2007 and 2008. They received 1.5% or 4.25% glucose during continuous ambulatory peritoneal dialysis (CAPD 1.5% or 4.25%), or 1.5% glucose continuous cycling peritoneal dialysis (CCPD 1.5%). Continuous glucose monitoring system and finger-stick were used to assess ISF and blood glucose levels for 72 hours, respectively. Sixteen patients (9 CAPD and 7 CCPD) were assessed.
Results : Median age, diabetes onset, and years on PD were 71, 17, and 1.5 years, respectively. There was strong correlation between ISF and blood glucose level (r = 0.937). The mean ISF glucose levels between dialysate and non-dialysate days were not significantly different (P = 0.08) in spite of higher total caloric intake on dialysate day (P = 0.049). However, in the CAPD 4.25% group, mean ISF glucose and total consumed calories were significantly higher on dialysate than non-dialysate day (P = 0.026 and 0.031, respectively). The difference disappeared after adjustment for food calories. ISF glucose started rising after a 15-minute infusion of dialysate then sustained till 4 hours with a mean increase of 55%.
Conclusions : The evidence suggested that high-glucose peritoneal dialysate can increase ISF glucose but the effect is confounded by food caloric intake.
Downloads
References
Dasgupta MK. Management of patients with type 2 diabetes on peritoneal dialysis. Adv Perit Dial 2005;21:120-2.
Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, et al. Performance evaluation of the minimed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000;2:49-56. https://doi.org/10.1089/152091500316737
McGahan L. Continuous glucose monitoring in the management of diabetes mellitus. Issues Emerg Health Technol 2002:1-4.
Poolsup N, Suksomboon N, Kyaw AM. Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (cgm) on glucose control in diabetes. Diabetol Metab Syndr 2013; 5:39.
https://doi.org/10.1186/1758-5996-5-39
Marshall J, Jennings P, Scott A, Fluck RJ, McIntyre CW. Glycemic control in diabetic capd patients assessed by continuous glucose monitoring system (cgms). Kidney Int 2003; 64:1480-6.
https://doi.org/10.1046/j.1523-1755.2003.00209.x
Schwing WD, Erhard P, Newman LN, Nodge MM, Czechanski BJ, Orlin SM, et al. Assessing 24-hour blood glucose patterns in diabetic paitents treated by peritoneal dialysis. Adv Perit Dial 2004; 20:213-6.
Skubala A, Zywiec J, Zelobowska K, Gumprecht J, Grzeszczak W. Continuous glucose monitoring system in 72-hour glucose profile assessment in patients with end-stage renal disease on maintenance continuous ambulatory peritoneal dialysis. Med Sci Monit 2010; 16.
Lee S, Chen Y, Tsai I, Yen C, Chueh S, Chuang H. Glycosylated hemoglobin and albumincorrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients. PLoS One 2013; 8:e57762. https://doi.org/10.1371/journal.pone.0057762
Harris JA, Benedict FG. A biometric study of human basal metabolism. Proc Natl Acad Sci U S A 1918;4:370-3. https://doi.org/10.1073/pnas.4.12.370
Reeves MM, Capra S. Predicting energy requirements in the clinical setting: Are current methods evidence based? Nutr Rev 2003; 61:143-51. https://doi.org/10.1301/nr.2003.apr.143-151
Fortes PC, Mendes JG, Gevert F, Aita C, Riella MC, Pecoits-Filho R. Continuous glycemic monitoring system (cgms) utility in diabetic patients undergoing peritoneal dialysis. Perit Dial Int 2007; 27:S14.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Chulalongkorn Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.